Results 161 to 170 of about 84,070 (218)
Therapeutic Potential Target of Adenosine for Epilepsy: Focusing on Its Interaction with the Molecular Epileptogenic Network. [PDF]
Zhao X, Deng J, Xiong Z, Li T.
europepmc +1 more source
Soluble CD163 as a Biomarker of Liver Fibrosis and Inflammation in Liver Transplant Recipients. [PDF]
Lauridsen EHE +7 more
europepmc +1 more source
Low risk of severe COVID-19 in vaccinated people with multiple sclerosis: a nationwide Norwegian study. [PDF]
Rasmussen TH +21 more
europepmc +1 more source
Characterization of a MERS-related betacoronavirus in Danish brown long-eared bats (Plecotus auritus). [PDF]
Johnston CM +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Chronic Focal Encephalitis (Rasmussen Syndrome): Six Cases
Epilepsia, 1988Summary: Six of 81 (7.4%) patients with medically intractable epilepsy treated by selective cortical excision at The Hospital for Sick Children, Toronto, Canada, since 1974 were found to have inflammatory changes in the excised specimens of cerebral cortex.
J H, Piatt +4 more
openaire +4 more sources
Rasmussen’s syndrome treated with anakinra
Journal of Neurology, 2023Rasmussen's encephalitis (RE) is a rare chronic neurological disorder, characterized by unilateral inflammation of the cerebral cortex, refractory focal epilepsy or epilepsia partialis continua, hemiparesis, and progressive cognitive decline. Interleukin-1 (IL-1) plays an important role in neuroinflammation as a key element in the activation of the ...
Abdullah Arcan +5 more
openaire +3 more sources
European Journal of Pediatrics, 2010
Rasmussen's syndrome (RS) is a rare acquired progressive inflammatory encephalopathy characterized by drug-resistant partial seizures and cognitive deterioration resulting from a gradual impairment and a subsequent atrophy of a single brain hemisphere. It was firstly described by Theodore Rasmussen in 1958.
MASTRANGELO, Mario +2 more
openaire +3 more sources
Rasmussen's syndrome (RS) is a rare acquired progressive inflammatory encephalopathy characterized by drug-resistant partial seizures and cognitive deterioration resulting from a gradual impairment and a subsequent atrophy of a single brain hemisphere. It was firstly described by Theodore Rasmussen in 1958.
MASTRANGELO, Mario +2 more
openaire +3 more sources
Neurological Sciences, 2003
Rasmussen's encephalitis (RE) is characterized by focal seizures, often associated with epilepsia partialis continua, progressive neurological deterioration, hemispheric atrophy, and inflammatory histopathology. Surgical exclusion of the affected hemisphere is the only treatment that halts progression of the disease.
openaire +2 more sources
Rasmussen's encephalitis (RE) is characterized by focal seizures, often associated with epilepsia partialis continua, progressive neurological deterioration, hemispheric atrophy, and inflammatory histopathology. Surgical exclusion of the affected hemisphere is the only treatment that halts progression of the disease.
openaire +2 more sources

